Resources

The Ultra Rice technology has been intensively studied to ensure it is efficacious, shelf stable, and acceptable to consumers. This table outlines the 30 studies conducted to date that form the growing evidence base for the Ultra Rice fortification technology.

Part of the Technology Updates series, this fact sheet describes PATH's work on intranasal and pulmonary delivery devices to administer vaccines.

This fact sheet highlights PATH's multifaceted approach to expanding vaccine solutions against influenza that are optimal for the developing world. It describes our efforts to advance the development of promising new influenza vaccines, gain a better understanding of influenza vaccine performance in children in low-resource countries, and help emerging-country manufacturers produce influenza vaccines for pandemic preparedness.

This fact sheet provides important information on the SA 14-14-2 JE vaccine manufactured by the Chengdu Institute of Biological Products. Topics include vaccine presentation, dosage, safety, and history of use.

Part of the Technology Updates series, this fact sheet describes the SoloShot project at PATH.